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There is a striking need for increased international co-
operation in scientific research on rare diseases (RDs).
Existing research efforts are in fact still scattered and
fragmented research is being performed with little coordi-
nation between research laboratories. This lack of coordi-
nation is particularly detrimental to the increase of
knowledge and to the delivery of new therapies for RDs
because the resources are very limited and the patient
population is small for each disease. Moreover, traditional
funding mechanisms based on natural market conditions
and access to public funds, do not fit the reality of
research requirements on RDs.
For these reasons the BLACKSWAN Foundation is
proud to present the RE(ACT) Initiative with the aim of
boosting research and facilitating the discovery of new
molecules and therapies for millions of patients. The
Initiative is structured on two main axes: the RE(ACT)
Congress (react-congress.org) and the online RE(ACT)
Community (react-community.org). Their mission is to
strengthen the synergies between researchers and other
stakeholders that are related to different extents with RDs.
The RE(ACT) Congress is organized every two years
and brings together world leaders and young scientists
from different scientific fields to present state-of-the-art
research, to discuss results and to exchange ideas.
The RE(ACT) Community as an example of how the use
of online communities and social media can address these
challenges and facilitate the cooperation between research-
ers, patients and other important stakeholders in the RDs
field. The RE(ACT) Community uses an innovative online
platform that combines elements of scientific knowledge
sharing with the access to new funding mechanisms to
improve the implementation of research projects. This
approach is conceived to empower researchers and
patients and change the way science is communicated.
The RE(ACT) Community is a place where everybody has
an equal opportunity to seek, share and generate knowl-
edge. Patients and patient organizations have the possibi-
lity to exchange their observations on a disease directly
with researchers and researchers can be put in contact
with patients who express the interest to take part in clini-
cal trials, provide samples, or support. Moreover, crowd-
funding is introduced as original financing method to
support research in the field of RDs as it involves funding
a project with relatively modest contributions from a large
group of individuals. The promotion of a research project
can be facilitated by social media through the integration
of “social plugin” on platforms, which allow a user to
sensitize his network and improve awareness on a specific
research or disease.
The RE(ACT) Community is a new kind of collaborative
workspace where RD stakeholders help each other
to develop research and increase awareness in the public
opinion on the subject of RDs.
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